泰凌医药2月10日起停牌 待刊发有关发行可转换债券的补充资料

Core Viewpoint - TaiLing Pharmaceutical (01011) announced that its shares will be suspended from trading on the Hong Kong Stock Exchange starting from 9:03 AM on February 10, 2026, pending the release of supplementary information regarding the announcement on the issuance of convertible bonds under general authorization dated February 9, 2026 [1] Group 1 - The suspension of trading is set to begin on February 10, 2026, at 9:03 AM [1] - The suspension is due to the pending release of supplementary information related to the issuance of convertible bonds [1] - The announcement regarding the convertible bonds was originally made on February 9, 2026 [1]